← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Clover Health grew revenue but losses and cash burn widened.
The read at a glance✓ Audited against SEC data
- Business mix — Medicare Advantage insurerNote
- Revenue — $1.92B, +40.3%OK
- Net loss — $85.5M, widerWatch
- FCF — ($69.0M), worseWatch
- Equity — $308.7M, -9.5%Watch
- Altman/Beneish/EQ — Weak Z; no M/EQWatch
- Insiders — 3 purchases / 12 salesNote
Business
Clover Health is a Medicare Advantage insurer using the Clover Assistant platform within its care model.
Where the revenue comes from
Fiscal 2025, as CLOVER HEALTH INVESTMENTS, CORP. /DE reports it. History and quarterly detail are in the app.
- Insurance Operations$1.9B
Leadership changes
From CLOVER HEALTH INVESTMENTS, CORP. /DE's own filings, the day they're filed.
- Brady Priest · Chief Executive Officer · departureeff. 2026-07-03
- Thomas L. Tran · Chairman · departureeff. 2025-06-10
- Thomas L. Tran · director · appointmenteff. 2024-08-20
Latest filings
- 8-K · Company announcement2026-08-20
- 10-Q · Quarterly report2026-08-07
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-07-17
- 8-K · Company announcement2026-06-18
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CLOVER HEALTH INVESTMENTS, CORP. /DE, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.